Out-of-hospital cardiac arrest is a major cause of death. It occurs when a person’s heart stops pumping blood around the body. It is most often caused
Why most opioid risk tools fail?
How many of you had a flu this winter? Anyone took antibiotics for that? But some people can’t take them because they are allergic. Now, imagine
As good as methadone if not better
Looking at an old drug repurposed to treat opioid addiction, a new study found long-acting formulation of morphine (SROM) promising for curbing the
Clinician-Scientist Training in Addiction Medicine
In a new article from the Academic Medicine, we argue that clinician-scientist training is one of the most important bridges to cross the growing
Double trouble: opioids and pain among people with substance use disorders
Against the use of opioids for chronic non-cancer pain to people who have active substance use disorders advises the third recommendation in the new
How can we do better job in studying Topiramate?
Topiramate prevents seizures in people with epilepsy. Previously, we looked at all studies to see whether Topiramate can help treat cocaine addiction,
Reducing drinking in illicit drug users: an impact story @COMETinitiative
Research impact is often hard to prove. It takes years before our findings change the world and the change is often small. This new abstract
International AIDS conference and the role of Drug Policy #IAS2015
Dr. Evan Wood speaks at #IAS2015 conference in Vancouver, on How Drug Policy should respond to the HIV Epidemic. International AIDS conference
Encouraging people to take part in studies of drug and mental health problems: New abstract out now
April 1st: Encouraging recruitment to clinical trials is a frequently reported problem. Challenges related to study design, communication,